Market Cap 95.73M
Revenue (ttm) 0.00
Net Income (ttm) -38.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.06
Volume 53,500
Avg Vol 48,912
Day's Range N/A - N/A
Shares Out 30.49M
Stochastic %K 5%
Beta 1.28
Analysts Strong Buy
Price Target $18.00

Latest News on XBIT

XBiotech Pauses Rheumatology program

Dec 23, 2024, 9:00 AM EST - 3 months ago

XBiotech Pauses Rheumatology program


What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday?

Jun 18, 2024, 1:08 PM EDT - 10 months ago

What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday?


XBiotech: Several Shots On Goal In Big Target Market Indications

May 24, 2024, 4:08 PM EDT - 11 months ago

XBiotech: Several Shots On Goal In Big Target Market Indications